ReviewDiscover nano2026
Nanoparticle based siRNA therapeutics for ovarian cancer overcoming drug resistance and future directions.
Roberta Di Fonte et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it